Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (19713)	3/13/1999 4:45:00 PM
From: Mkilloran	Read Replies (1) \| Respond to of 23519

Vlad,,,starting to see some good questions raised on VVUS. ...have they been waiting on the female SD patent to use as a chip in the USA partner negotiations?? ..Vivus stated it thought it could get a female SD product approved (if all things work out) in 1-2 years. ...Question ...what would cause the female SD topical gel/cream to be sold as an over the counter product vrs a prescription product??? And which would be more profitable long term over the counter or prescription???